Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-γ, pioglitazone

被引:83
|
作者
Enomoto, N [1 ]
Takei, Y [1 ]
Hirose, M [1 ]
Konno, A [1 ]
Shibuya, T [1 ]
Matsuyama, S [1 ]
Suzuki, S [1 ]
Ikejima, K [1 ]
Kitamura, T [1 ]
Sato, N [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138421, Japan
关键词
D O I
10.1124/jpet.102.047217
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Agonists of peroxisome proliferator-activated receptor (PPAR)-gamma have been shown to reduce tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance. On the other hand, sensitization of Kupffer cells to lipopolysaccharide (LPS) and their production of TNF-alpha are critical for progression of alcoholic liver injury. This study was intended to determine whether pioglitazone, a PPAR-gamma agonist, could prevent alcohol-induced liver injury. Rats were given ethanol (5 g/kg b.wt.) and pioglitazone (500 mug/kg) once every 24 h intragastrically. Ethanol for 8 weeks caused pronounced steatosis, necrosis, and inflammation in the liver. These pathological parameters were diminished greatly by pioglitazone. Kupffer cells were sensitized to LPS after ethanol for 4 weeks as evidenced by aggravation of liver pathology induced by LPS (5 mg/kg) and enhancement of LPS (100 ng/ml)-induced intracellular Ca2+ concentration elevation in Kupffer cells. The parameters were diminished by treatment with pioglitazone. LPS-induced TNF-alpha production by Kupffer cells from the 4-week ethanol group was 3 to 4 times higher than control. This increase was blunted by 70% with pioglitazone. Gut permeability was 10-fold higher in the 4-week ethanol group, and pioglitazone treatment did not change the value. Inclusion of TNF-alpha in culture media of Kupffer cells enhanced CD14 expression, LPS-induced intracellular Ca2+ concentration response, and production of TNF-alpha. These results indicate that pioglitazone prevents alcoholic liver injury through abrogation of Kupffer cell sensitization to LPS.
引用
收藏
页码:846 / 854
页数:9
相关论文
共 50 条
  • [21] Inflammation in diabetes mellitus:: Role of peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-γ agonists
    Libby, Peter
    Plutzky, Jorge
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (4A): : 27B - 40B
  • [22] Role of Peroxisome Proliferator-activated Receptor-α in Hepatobiliary Injury Induced by Ammonium Perfluorooctanoate in Mouse Liver
    Minata, Mutsuko
    Harada, Kouji H.
    Karrman, Anna
    Hitomi, Toshiaki
    Hirosawa, Michi
    Murata, Mariko
    Gonzalez, Frank J.
    Koizumi, Akio
    INDUSTRIAL HEALTH, 2010, 48 (01) : 96 - 107
  • [23] Pioglitazone, a Ligand for Peroxisome Proliferator-activated Receptor-γ Acts as an Inhibitor of Colon Cancer Liver Metastasis
    Takano, Shota
    Kubota, Tetsuro
    Nishibori, Hideki
    Hasegawa, Hirotoshi
    Ishii, Yoshiyuki
    Nitori, Nobuhiro
    Ochiai, Hiroki
    Okabayashi, Koji
    Kitagawa, Yuko
    Watanabe, Masahiko
    Kitajima, Masaki
    ANTICANCER RESEARCH, 2008, 28 (6A) : 3593 - 3599
  • [24] Renal-Protective Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone in ob/ob Mice
    Li, Ying
    Xia, Tian
    Li, Rong
    Tse, Gary
    Liu, Tong
    Li, Guangping
    MEDICAL SCIENCE MONITOR, 2019, 25 : 1582 - 1589
  • [25] Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease
    Breidert, T
    Callebert, J
    Heneka, MT
    Landreth, G
    Launay, JM
    Hirsch, EC
    JOURNAL OF NEUROCHEMISTRY, 2002, 82 (03) : 615 - 624
  • [26] Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in rats
    Ma, LJ
    Marcantoni, C
    Linton, MF
    Fazio, S
    Fogo, AB
    KIDNEY INTERNATIONAL, 2001, 59 (05) : 1899 - 1910
  • [27] Peroxisome proliferator-activated receptor-γ and lipodystrophy
    Tantsma, Jouke T.
    Rabelink, Ton J.
    FUTURE LIPIDOLOGY, 2006, 1 (04): : 455 - 462
  • [28] Effects of peroxisome proliferator-activated receptor-β/δ on sepsis induced acute lung injury
    Wang Cairui
    Zhou Guopeng
    Zeng Zeng
    中华医学杂志(英文版), 2014, (11) : 2129 - 2137
  • [29] Effects of peroxisome proliferator-activated receptor-β/δ on sepsis induced acute lung injury
    Wang Cairui
    Zhou Guopeng
    Zeng Zeng
    CHINESE MEDICAL JOURNAL, 2014, 127 (11) : 2129 - 2137
  • [30] Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced glomerular injury
    Zhou, Yunfeng
    Kong, Xiaomu
    Zhao, Pan
    Yang, Hang
    Chen, Lihong
    Miao, Jing
    Zhang, Xiaoyan
    Yang, Jichun
    Ding, Jie
    Guan, Youfei
    KIDNEY INTERNATIONAL, 2011, 79 (12) : 1302 - 1311